aluates Reports

$ 0.0

Automative

Global Lung Cancer Liquid Biopsy Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-33U5906

Global Lung Cancer Liquid Biopsy Market Insights and Forecast to 2028

BUY CHAPTERS

Global Lung Cancer Liquid Biopsy Market Research Report 2025

Code: QYRE-Auto-33U5906

Report

September 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Qiagen NV

Biocept

RainDanceTechnologies

Biocartis

Guardant Health

MDxHealth

Pathway Genomics

NeoGenomics Laboraories

Sysmex Inostics

Cynvenio

Menarini Silicon Biosystems

Adaptive Biotechnologies

Angle plc

Lung Cancer Liquid Biopsy Market Size

The global market for Lung Cancer Liquid Biopsy was valued at US$ 555 million in the year 2024 and is projected to reach a revised size of US$ 1372 million by 2031, growing at a CAGR of 14.0% during the forecast period.

Lung Cancer Liquid Biopsy Market

North American market for Lung Cancer Liquid Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lung Cancer Liquid Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Lung Cancer Liquid Biopsy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Lung Cancer Liquid Biopsy include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, Menarini Silicon Biosystems, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Liquid Biopsy.

The Lung Cancer Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Liquid Biopsy Market Report

Report Metric	Details
Report Name	Lung Cancer Liquid Biopsy Market
Accounted market size in year	US$ 555 million
Forecasted market size in 2031	US$ 1372 million
CAGR	14.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Exosomes and RNA CTCs and ctDNA
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, Menarini Silicon Biosystems, Adaptive Biotechnologies, Biocept, Angle plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Liquid Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lung Cancer Liquid Biopsy Market growing?

Ans: The Lung Cancer Liquid Biopsy Market witnessing a CAGR of 14.0% during the forecast period 2025-2031.

What is the Lung Cancer Liquid Biopsy Market size in 2031?

Ans: The Lung Cancer Liquid Biopsy Market size in 2031 will be US$ 1372 million.

Who are the main players in the Lung Cancer Liquid Biopsy Market report?

Ans: The main players in the Lung Cancer Liquid Biopsy Market are RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, Menarini Silicon Biosystems, Adaptive Biotechnologies, Biocept, Angle plc

What are the Application segmentation covered in the Lung Cancer Liquid Biopsy Market report?

Ans: The Applications covered in the Lung Cancer Liquid Biopsy Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Lung Cancer Liquid Biopsy Market report?

Ans: The Types covered in the Lung Cancer Liquid Biopsy Market report are Exosomes and RNA, CTCs and ctDNA

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Exosomes and RNA

1.2.3 CTCs and ctDNA

1.3 Market by Application

1.3.1 Global Lung Cancer Liquid Biopsy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2020-2031)

2.2 Global Lung Cancer Liquid Biopsy Growth Trends by Region

2.2.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lung Cancer Liquid Biopsy Historic Market Size by Region (2020-2025)

2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Region (2026-2031)

2.3 Lung Cancer Liquid Biopsy Market Dynamics

2.3.1 Lung Cancer Liquid Biopsy Industry Trends

2.3.2 Lung Cancer Liquid Biopsy Market Drivers

2.3.3 Lung Cancer Liquid Biopsy Market Challenges

2.3.4 Lung Cancer Liquid Biopsy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue

3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2020-2025)

3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2020-2025)

3.2 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lung Cancer Liquid Biopsy Revenue

3.4 Global Lung Cancer Liquid Biopsy Market Concentration Ratio

3.4.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2024

3.5 Global Key Players of Lung Cancer Liquid Biopsy Head office and Area Served

3.6 Global Key Players of Lung Cancer Liquid Biopsy, Product and Application

3.7 Global Key Players of Lung Cancer Liquid Biopsy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biopsy Breakdown Data by Type

4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2020-2025)

4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2026-2031)

5 Lung Cancer Liquid Biopsy Breakdown Data by Application

5.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2020-2025)

5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lung Cancer Liquid Biopsy Market Size (2020-2031)

6.2 North America Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lung Cancer Liquid Biopsy Market Size by Country (2020-2025)

6.4 North America Lung Cancer Liquid Biopsy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Liquid Biopsy Market Size (2020-2031)

7.2 Europe Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lung Cancer Liquid Biopsy Market Size by Country (2020-2025)

7.4 Europe Lung Cancer Liquid Biopsy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size (2020-2031)

8.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2020-2025)

8.4 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Liquid Biopsy Market Size (2020-2031)

9.2 Latin America Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2020-2025)

9.4 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size (2020-2031)

10.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2020-2025)

10.4 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 RainDanceTechnologies

11.1.1 RainDanceTechnologies Company Details

11.1.2 RainDanceTechnologies Business Overview

11.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Introduction

11.1.4 RainDanceTechnologies Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.1.5 RainDanceTechnologies Recent Development

11.2 Biocartis

11.2.1 Biocartis Company Details

11.2.2 Biocartis Business Overview

11.2.3 Biocartis Lung Cancer Liquid Biopsy Introduction

11.2.4 Biocartis Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.2.5 Biocartis Recent Development

11.3 Qiagen

11.3.1 Qiagen Company Details

11.3.2 Qiagen Business Overview

11.3.3 Qiagen Lung Cancer Liquid Biopsy Introduction

11.3.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.3.5 Qiagen Recent Development

11.4 Guardant Health

11.4.1 Guardant Health Company Details

11.4.2 Guardant Health Business Overview

11.4.3 Guardant Health Lung Cancer Liquid Biopsy Introduction

11.4.4 Guardant Health Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.4.5 Guardant Health Recent Development

11.5 MDxHealth

11.5.1 MDxHealth Company Details

11.5.2 MDxHealth Business Overview

11.5.3 MDxHealth Lung Cancer Liquid Biopsy Introduction

11.5.4 MDxHealth Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.5.5 MDxHealth Recent Development

11.6 Pathway Genomics

11.6.1 Pathway Genomics Company Details

11.6.2 Pathway Genomics Business Overview

11.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Introduction

11.6.4 Pathway Genomics Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.6.5 Pathway Genomics Recent Development

11.7 NeoGenomics Laboraories

11.7.1 NeoGenomics Laboraories Company Details

11.7.2 NeoGenomics Laboraories Business Overview

11.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Introduction

11.7.4 NeoGenomics Laboraories Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.7.5 NeoGenomics Laboraories Recent Development

11.8 Sysmex Inostics

11.8.1 Sysmex Inostics Company Details

11.8.2 Sysmex Inostics Business Overview

11.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Introduction

11.8.4 Sysmex Inostics Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.8.5 Sysmex Inostics Recent Development

11.9 Cynvenio

11.9.1 Cynvenio Company Details

11.9.2 Cynvenio Business Overview

11.9.3 Cynvenio Lung Cancer Liquid Biopsy Introduction

11.9.4 Cynvenio Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.9.5 Cynvenio Recent Development

11.10 Menarini Silicon Biosystems

11.10.1 Menarini Silicon Biosystems Company Details

11.10.2 Menarini Silicon Biosystems Business Overview

11.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Introduction

11.10.4 Menarini Silicon Biosystems Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.10.5 Menarini Silicon Biosystems Recent Development

11.11 Adaptive Biotechnologies

11.11.1 Adaptive Biotechnologies Company Details

11.11.2 Adaptive Biotechnologies Business Overview

11.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Introduction

11.11.4 Adaptive Biotechnologies Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.11.5 Adaptive Biotechnologies Recent Development

11.12 Biocept

11.12.1 Biocept Company Details

11.12.2 Biocept Business Overview

11.12.3 Biocept Lung Cancer Liquid Biopsy Introduction

11.12.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.12.5 Biocept Recent Development

11.13 Angle plc

11.13.1 Angle plc Company Details

11.13.2 Angle plc Business Overview

11.13.3 Angle plc Lung Cancer Liquid Biopsy Introduction

11.13.4 Angle plc Revenue in Lung Cancer Liquid Biopsy Business (2020-2025)

11.13.5 Angle plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Qiagen NV

Biocept

RainDanceTechnologies

Biocartis

Guardant Health

MDxHealth

Pathway Genomics

NeoGenomics Laboraories

Sysmex Inostics

Cynvenio

Menarini Silicon Biosystems

Adaptive Biotechnologies

Angle plc

List of Tables

Table 1. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Exosomes and RNA

Table 3. Key Players of CTCs and ctDNA

Table 4. Global Lung Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Lung Cancer Liquid Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Lung Cancer Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Lung Cancer Liquid Biopsy Market Share by Region (2020-2025)

Table 8. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Lung Cancer Liquid Biopsy Market Share by Region (2026-2031)

Table 10. Lung Cancer Liquid Biopsy Market Trends

Table 11. Lung Cancer Liquid Biopsy Market Drivers

Table 12. Lung Cancer Liquid Biopsy Market Challenges

Table 13. Lung Cancer Liquid Biopsy Market Restraints

Table 14. Global Lung Cancer Liquid Biopsy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Lung Cancer Liquid Biopsy Market Share by Players (2020-2025)

Table 16. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2024)

Table 17. Ranking of Global Top Lung Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Lung Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Lung Cancer Liquid Biopsy, Headquarters and Area Served

Table 20. Global Key Players of Lung Cancer Liquid Biopsy, Product and Application

Table 21. Global Key Players of Lung Cancer Liquid Biopsy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Lung Cancer Liquid Biopsy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2020-2025)

Table 25. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2026-2031)

Table 27. Global Lung Cancer Liquid Biopsy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2020-2025)

Table 29. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2026-2031)

Table 31. North America Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Lung Cancer Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Lung Cancer Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Lung Cancer Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Lung Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 46. RainDanceTechnologies Company Details

Table 47. RainDanceTechnologies Business Overview

Table 48. RainDanceTechnologies Lung Cancer Liquid Biopsy Product

Table 49. RainDanceTechnologies Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 50. RainDanceTechnologies Recent Development

Table 51. Biocartis Company Details

Table 52. Biocartis Business Overview

Table 53. Biocartis Lung Cancer Liquid Biopsy Product

Table 54. Biocartis Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 55. Biocartis Recent Development

Table 56. Qiagen Company Details

Table 57. Qiagen Business Overview

Table 58. Qiagen Lung Cancer Liquid Biopsy Product

Table 59. Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 60. Qiagen Recent Development

Table 61. Guardant Health Company Details

Table 62. Guardant Health Business Overview

Table 63. Guardant Health Lung Cancer Liquid Biopsy Product

Table 64. Guardant Health Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 65. Guardant Health Recent Development

Table 66. MDxHealth Company Details

Table 67. MDxHealth Business Overview

Table 68. MDxHealth Lung Cancer Liquid Biopsy Product

Table 69. MDxHealth Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 70. MDxHealth Recent Development

Table 71. Pathway Genomics Company Details

Table 72. Pathway Genomics Business Overview

Table 73. Pathway Genomics Lung Cancer Liquid Biopsy Product

Table 74. Pathway Genomics Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 75. Pathway Genomics Recent Development

Table 76. NeoGenomics Laboraories Company Details

Table 77. NeoGenomics Laboraories Business Overview

Table 78. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product

Table 79. NeoGenomics Laboraories Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 80. NeoGenomics Laboraories Recent Development

Table 81. Sysmex Inostics Company Details

Table 82. Sysmex Inostics Business Overview

Table 83. Sysmex Inostics Lung Cancer Liquid Biopsy Product

Table 84. Sysmex Inostics Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 85. Sysmex Inostics Recent Development

Table 86. Cynvenio Company Details

Table 87. Cynvenio Business Overview

Table 88. Cynvenio Lung Cancer Liquid Biopsy Product

Table 89. Cynvenio Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 90. Cynvenio Recent Development

Table 91. Menarini Silicon Biosystems Company Details

Table 92. Menarini Silicon Biosystems Business Overview

Table 93. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product

Table 94. Menarini Silicon Biosystems Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 95. Menarini Silicon Biosystems Recent Development

Table 96. Adaptive Biotechnologies Company Details

Table 97. Adaptive Biotechnologies Business Overview

Table 98. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product

Table 99. Adaptive Biotechnologies Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 100. Adaptive Biotechnologies Recent Development

Table 101. Biocept Company Details

Table 102. Biocept Business Overview

Table 103. Biocept Lung Cancer Liquid Biopsy Product

Table 104. Biocept Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 105. Biocept Recent Development

Table 106. Angle plc Company Details

Table 107. Angle plc Business Overview

Table 108. Angle plc Lung Cancer Liquid Biopsy Product

Table 109. Angle plc Revenue in Lung Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 110. Angle plc Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Lung Cancer Liquid Biopsy Picture

Figure 2. Global Lung Cancer Liquid Biopsy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lung Cancer Liquid Biopsy Market Share by Type: 2024 VS 2031

Figure 4. Exosomes and RNA Features

Figure 5. CTCs and ctDNA Features

Figure 6. Global Lung Cancer Liquid Biopsy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Lung Cancer Liquid Biopsy Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Lung Cancer Liquid Biopsy Report Years Considered

Figure 12. Global Lung Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Lung Cancer Liquid Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Lung Cancer Liquid Biopsy Market Share by Region: 2024 VS 2031

Figure 15. Global Lung Cancer Liquid Biopsy Market Share by Players in 2024

Figure 16. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2024

Figure 18. North America Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Lung Cancer Liquid Biopsy Market Share by Country (2020-2031)

Figure 20. United States Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Lung Cancer Liquid Biopsy Market Share by Country (2020-2031)

Figure 24. Germany Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Region (2020-2031)

Figure 32. China Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Lung Cancer Liquid Biopsy Market Share by Country (2020-2031)

Figure 40. Mexico Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Country (2020-2031)

Figure 44. Turkey Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Lung Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. RainDanceTechnologies Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 48. Biocartis Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 49. Qiagen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 50. Guardant Health Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 51. MDxHealth Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 52. Pathway Genomics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 53. NeoGenomics Laboraories Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 54. Sysmex Inostics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 55. Cynvenio Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 56. Menarini Silicon Biosystems Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 57. Adaptive Biotechnologies Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 58. Biocept Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 59. Angle plc Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Liquid Biopsy Technology Market Research Report 2025

Global Circulating Biomarker for Liquid Biopsy Market Research Report 2024

Global Liquid Biopsy Tube Market Research Report 2024

Global Cancer Cell Biopsy Service Market Research Report 2025

Tumor Fluid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Biopsy Needle Market Research Report 2024

Circulating Tumor Cells CTC Liquid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Screening Software Market Research Report 2024

Global Liquid Biopsy Test Kit Market Research Report 2024

Fusion Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Genomic Testing Market Research Report 2024

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Extracellular Vesicles Based Liquid Biopsy Market Research Report 2024

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Cytological Biopsy Needle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Circulating Tumor Cell Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Cancer Biological Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions